Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Aug;40(8):1541-1549.
doi: 10.1007/s10072-019-03877-5. Epub 2019 Apr 13.

The potential roles of aquaporin 4 in amyotrophic lateral sclerosis

Shuang Zou  1   2   3   4 , Yu-Long Lan  2   4 , Hongjin Wang  3 , Bo Zhang  5   6 , Yan-Guo Sun  7
Affiliations
Review

The potential roles of aquaporin 4 in amyotrophic lateral sclerosis

Shuang Zou et al. Neurol Sci. 2019 Aug.

Abstract

Aquaporin 4 (AQP4) is a primary water channel found on astrocytes in the central nervous system (CNS). Besides its function in water and ion homeostasis, AQP4 has also been documented to be involved in a myriad of acute and chronic cerebral pathologies, including autoimmune neurodegenerative diseases. AQP4 has been postulated to be associated with the incidence of a progressive neurodegenerative disorder known as amyotrophic lateral sclerosis (ALS), a disease that targets the motor neurons, causing muscle weakness and eventually paralysis. Raised AQP4 levels were noted in association with vessels surrounded with swollen astrocytic processes as well as in the brainstem, cortex, and gray matter in patients with terminal ALS. AQP4 depolarization may lead to motor neuron degeneration in ALS via GLT-1. Besides, alterations in AQP4 expression in ALS may result in the loss of blood-brain barrier (BBB) integrity. Changes in AQP4 function may also disrupt K+ homeostasis and cause connexin dysregulation, the latter of which is associated to ALS disease progression. Furthermore, AQP4 suppression augments recovery in motor function in ALS, a phenomenon thought to be associated to NGF. No therapeutic drug targeting AQP4 has been developed to date. Nevertheless, the plethora of suggestive experimental results underscores the significance of further exploration into this area.

Keywords: AQP4; Amyotrophic lateral sclerosis; Target; Therapy.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Nat Med. 2000 Feb;6(2):159-63 - PubMed
    1. J Neurosci. 2001 Mar 15;21(6):1983-2000 - PubMed
    1. Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1604-9 - PubMed
    1. Brain. 2003 Apr;126(Pt 4):965-73 - PubMed
    1. N Engl J Med. 1992 May 28;326(22):1464-8 - PubMed

MeSH terms

LinkOut - more resources